vs
Axos Financial, Inc.（AX）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Axos Financial, Inc.的1.6倍（$622.0M vs $392.2M），Royalty Pharma plc净利率更高（34.4% vs 31.8%，领先2.7%），过去两年Axos Financial, Inc.的营收复合增速更高（16.1% vs 4.6%）
Axos Financial是总部位于美国内华达州拉斯维加斯的银行控股公司，旗下拥有直销银行Axos Bank，同时提供注册投资顾问服务及电子交易平台，深耕数字化金融赛道，可为用户提供多元便捷的金融服务解决方案。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
AX vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.6倍
$392.2M
净利率更高
RPRX
高出2.7%
31.8%
两年增速更快
AX
近两年复合增速
4.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $392.2M | $622.0M |
| 净利润 | $124.7M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 31.8% | 34.4% |
| 营收同比 | — | 4.8% |
| 净利润同比 | 18.5% | 2.9% |
| 每股收益（稀释后） | $2.15 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXRPRX
| Q1 26 | $392.2M | — | ||
| Q4 25 | $385.1M | $622.0M | ||
| Q3 25 | $323.4M | $609.3M | ||
| Q2 25 | $321.4M | $578.7M | ||
| Q1 25 | $308.8M | $568.2M | ||
| Q4 24 | $307.9M | $593.6M | ||
| Q3 24 | $320.7M | $564.7M | ||
| Q2 24 | $290.9M | $537.3M |
净利润AXRPRX
| Q1 26 | $124.7M | — | ||
| Q4 25 | $128.4M | $214.2M | ||
| Q3 25 | $112.4M | $288.2M | ||
| Q2 25 | $110.7M | $30.2M | ||
| Q1 25 | $105.2M | $238.3M | ||
| Q4 24 | $104.7M | $208.2M | ||
| Q3 24 | $112.3M | $544.0M | ||
| Q2 24 | $104.9M | $102.0M |
营业利润率AXRPRX
| Q1 26 | — | — | ||
| Q4 25 | 45.6% | 62.4% | ||
| Q3 25 | 46.3% | 70.1% | ||
| Q2 25 | 48.5% | 36.3% | ||
| Q1 25 | 47.9% | 94.0% | ||
| Q4 24 | 48.8% | 60.9% | ||
| Q3 24 | 49.6% | — | ||
| Q2 24 | 49.6% | 50.2% |
净利率AXRPRX
| Q1 26 | 31.8% | — | ||
| Q4 25 | 33.3% | 34.4% | ||
| Q3 25 | 34.7% | 47.3% | ||
| Q2 25 | 34.4% | 5.2% | ||
| Q1 25 | 34.1% | 41.9% | ||
| Q4 24 | 34.0% | 35.1% | ||
| Q3 24 | 35.0% | 96.3% | ||
| Q2 24 | 36.0% | 19.0% |
每股收益（稀释后）AXRPRX
| Q1 26 | $2.15 | — | ||
| Q4 25 | $2.22 | $0.49 | ||
| Q3 25 | $1.94 | $0.67 | ||
| Q2 25 | $1.89 | $0.07 | ||
| Q1 25 | $1.81 | $0.55 | ||
| Q4 24 | $1.80 | $0.46 | ||
| Q3 24 | $1.93 | $1.21 | ||
| Q2 24 | $1.75 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $3.1B | $9.7B |
| 总资产 | $29.2B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资AXRPRX
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $618.7M | ||
| Q3 25 | $2.6B | $938.9M | ||
| Q2 25 | $1.9B | $631.9M | ||
| Q1 25 | $2.0B | $1.1B | ||
| Q4 24 | $2.4B | $929.0M | ||
| Q3 24 | $2.6B | $950.1M | ||
| Q2 24 | $2.0B | $1.8B |
总债务AXRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | $312.7M | $8.0B | ||
| Q1 25 | $377.4M | $7.6B | ||
| Q4 24 | $358.7M | $7.6B | ||
| Q3 24 | $313.5M | $7.6B | ||
| Q2 24 | $325.7M | $7.6B |
股东权益AXRPRX
| Q1 26 | $3.1B | — | ||
| Q4 25 | $2.9B | $9.7B | ||
| Q3 25 | $2.8B | $9.6B | ||
| Q2 25 | $2.7B | $9.5B | ||
| Q1 25 | $2.6B | $9.8B | ||
| Q4 24 | $2.5B | $10.3B | ||
| Q3 24 | $2.4B | $10.3B | ||
| Q2 24 | $2.3B | $9.8B |
总资产AXRPRX
| Q1 26 | $29.2B | — | ||
| Q4 25 | $28.2B | $19.6B | ||
| Q3 25 | $27.4B | $19.3B | ||
| Q2 25 | $24.8B | $18.3B | ||
| Q1 25 | $24.0B | $17.6B | ||
| Q4 24 | $23.7B | $18.2B | ||
| Q3 24 | $23.6B | $18.0B | ||
| Q2 24 | $22.9B | $17.7B |
负债/权益比AXRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | 0.12× | 0.84× | ||
| Q1 25 | 0.14× | 0.78× | ||
| Q4 24 | 0.14× | 0.74× | ||
| Q3 24 | 0.13× | 0.74× | ||
| Q2 24 | 0.14× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AXRPRX
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $827.1M | ||
| Q3 25 | $118.4M | $702.6M | ||
| Q2 25 | $490.3M | $364.0M | ||
| Q1 25 | $73.7M | $596.1M | ||
| Q4 24 | $162.5M | $742.5M | ||
| Q3 24 | $70.8M | $703.6M | ||
| Q2 24 | $305.5M | $658.2M |
自由现金流AXRPRX
| Q1 26 | — | — | ||
| Q4 25 | $85.4M | — | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | $436.1M | — | ||
| Q1 25 | $65.1M | — | ||
| Q4 24 | $156.4M | — | ||
| Q3 24 | $53.0M | — | ||
| Q2 24 | $269.5M | — |
自由现金流率AXRPRX
| Q1 26 | — | — | ||
| Q4 25 | 22.2% | — | ||
| Q3 25 | 33.8% | — | ||
| Q2 25 | 135.7% | — | ||
| Q1 25 | 21.1% | — | ||
| Q4 24 | 50.8% | — | ||
| Q3 24 | 16.5% | — | ||
| Q2 24 | 92.6% | — |
资本支出强度AXRPRX
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 16.9% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 12.4% | — |
现金转化率AXRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.81× | 3.86× | ||
| Q3 25 | 1.05× | 2.44× | ||
| Q2 25 | 4.43× | 12.06× | ||
| Q1 25 | 0.70× | 2.50× | ||
| Q4 24 | 1.55× | 3.57× | ||
| Q3 24 | 0.63× | 1.29× | ||
| Q2 24 | 2.91× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AX
| Net Interest Income | $306.3M | 78% |
| Noninterest Income | $86.0M | 22% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
